OPST (OPT Sciences) ROE %: 11.28% (As of Jul. 2015)


What is OPT Sciences ROE %?

OPT Sciences OPST +13.75% ROE % is 11.28% as of Jul. 2015.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. OPT Sciences's annualized net income for the quarter that ended in Jul. 2015 was $1.70 Mil. OPT Sciences's average Total Stockholders Equity over the quarter that ended in Jul. 2015 was $15.07 Mil. Therefore, OPT Sciences's annualized ROE % for the quarter that ended in Jul. 2015 was 11.28%.

The historical rank and industry rank for OPT Sciences's ROE % or its related term are showing as below:

OPST's ROE % is not ranked *
in the Aerospace & Defense industry.
Industry Median: 5.91
* Ranked among companies with meaningful ROE % only.

OPT Sciences  (OTCPK:OPST) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jul. 2015 )
=Net Income/Total Stockholders Equity
=1.7/15.069
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1.7 / 7.9)*(7.9 / 15.6925)*(15.6925 / 15.069)
=Net Margin %*Asset Turnover*Equity Multiplier
=21.52 %*0.5034*1.0414
=ROA %*Equity Multiplier
=10.83 %*1.0414
=11.28 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jul. 2015 )
=Net Income/Total Stockholders Equity
=1.7/15.069
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (1.7 / 2.784) * (2.784 / 2.308) * (2.308 / 7.9) * (7.9 / 15.6925) * (15.6925 / 15.069)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6106 * 1.2062 * 29.22 % * 0.5034 * 1.0414
=11.28 %

Note: The net income data used here is four times the quarterly (Jul. 2015) net income data. The Revenue data used here is four times the quarterly (Jul. 2015) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


OPT Sciences ROE % Related Terms


OPT Sciences ROE % Historical Data

* Premium members only.

The historical data trend for OPT Sciences's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPT Sciences ROE % Chart

OPT Sciences Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.41 7.78 7.78 7.34 8.18

OPT Sciences Quarterly Data
Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.27 12.74 7.20 11.01 11.28

OPST vs SDEV, SIF, OPXS: ROE % Comparison

For the Aerospace & Defense subindustry, OPT Sciences's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPT Sciences ROE % vs Aerospace & Defense Industry

For the Aerospace & Defense industry and Industrials sector, OPT Sciences's ROE % distribution charts can be found below:

* The bar in red indicates where OPT Sciences's ROE % falls into.



OPT Sciences ROE % Calculation

OPT Sciences's annualized ROE % for the fiscal year that ended in Oct. 2014 is calculated as

ROE %=Net Income (A: Oct. 2014 )/( (Total Stockholders Equity (A: Oct. 2013 )+Total Stockholders Equity (A: Oct. 2014 ))/ count )
=1.114/( (13.06+14.173)/ 2 )
=1.114/13.6165
=8.18 %

OPT Sciences's annualized ROE % for the quarter that ended in Jul. 2015 is calculated as

ROE %=Net Income (Q: Jul. 2015 )/( (Total Stockholders Equity (Q: Apr. 2015 )+Total Stockholders Equity (Q: Jul. 2015 ))/ count )
=1.7/( (14.884+15.254)/ 2 )
=1.7/15.069
=11.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jul. 2015) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 11.28% mean?
OPT Sciences (OPST) has a ROE % of 11.28% as of Jul. 2015. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on OPT Sciences and its competitors.
Is OPT Sciences' ROE % too high?
OPT Sciences' current ROE % is 11.28%. The Aerospace & Defense industry median ROE % is 5.91. OPT Sciences' value of 11.28% is 90.9% above this industry median.
How does OPT Sciences' ROE % compare to SDEV and SIF?
OPT Sciences' ROE % of 11.28% can be compared against companies in the Aerospace & Defense industry. The industry median ROE % is 5.91. OPT Sciences' value of 11.28% is 90.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Aerospace & Defense company?
The median ROE % among Aerospace & Defense companies is 5.91, based on 347 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OPT Sciences's current ROE % of 11.28% is 90.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on OPT Sciences and its competitors. For the Aerospace & Defense industry, the median ROE % is 5.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OPT Sciences's current ROE % is 11.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPT Sciences stock overvalued right now?
OPT Sciences (OPST) has a current ROE % of 11.28%. The current ROE % is 11.28% and 90.9% above the Aerospace & Defense industry median of 5.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For OPT Sciences (OPST), the current ROE % is 11.28% as of Jul. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OPT Sciences Business Description

Address 1912 Bannard Street, Cinnaminson, NJ, USA, 08077
OPT Sciences Corp through its operating subsidiary O & S Research, manufactures precision optical components for the Aerospace Industry. It provides anti-glare optical coatings, panels for liquid crystal displays ("LCD"), LCD glass heaters, and electromagnetic interference shielding glass. In addition, it also offers glass cutting, grinding, and painting services. Geographically, the activities are performed in the United States and it derives revenue from product sales when products are shipped to customers.